OutliveAPOE4 Weekly DigestNew studies, articles, and developments relevant to APOE4 carriers, distilled into short summaries.https://outliveapoe4.com/en-usWhy APOE genotype now matters for new Alzheimer’s drugshttps://outliveapoe4.com/digest/anti-amyloid-drugs-and-apoe4-aria/https://outliveapoe4.com/digest/anti-amyloid-drugs-and-apoe4-aria/The arrival of anti-amyloid antibodies makes your APOE status relevant to treatment safety, not just to risk. The short version.Tue, 02 Jun 2026 00:00:00 GMTresearchtreatmentlecanemabdonanemabARIABlood pressure belongs on your brain-health checklisthttps://outliveapoe4.com/digest/blood-pressure-brain-checklist/https://outliveapoe4.com/digest/blood-pressure-brain-checklist/Often symptomless, and one of the best-established modifiable dementia risk factors. Don’t let it slip under the radar.Tue, 02 Jun 2026 00:00:00 GMTheartblood-pressurepreventionvascularWelcome to the APOE4 Weekly Digesthttps://outliveapoe4.com/digest/welcome-to-the-digest/https://outliveapoe4.com/digest/welcome-to-the-digest/What this digest is, who it’s for, and how to get the most out of it.Mon, 01 Jun 2026 00:00:00 GMTbasicsmetagetting-startedMuch of dementia risk runs through factors you can influencehttps://outliveapoe4.com/digest/modifiable-risk-and-dementia/https://outliveapoe4.com/digest/modifiable-risk-and-dementia/Why the modifiable-risk-factor framing matters so much for APOE4 carriers, and what the WHO actually says about reducing risk.Sun, 31 May 2026 00:00:00 GMTbrainpreventionlifestyleresearch